TECX
Price:
$30.02
Market Cap:
$566.45M
Tectonic Therapeutic, Inc. operates as a clinical-stage biotechnology firm dedicated to the identification and progression of biologic therapies, primarily therapeutic proteins and antibodies, that regulate the function of G-protein coupled receptors (GPCRs). The company leverages its proprietary GEODe technology platform to facilitate the discovery and development of these GPCR-targeted medicines. Its robust pipeline includes an RXFP1 agonist, currently undergoing Phase 1a and 1b clinical trials for the treatment of heart failure with preserved ejection fraction. Additional programs encompass a GPCR antagonist addressing hereditary hemorrhagic telangiectasia, a bi-functional GPCR modulator ...[Read more]
Industry
Biotechnology
IPO Date
2018-06-21
Stock Exchange
NASDAQ
Ticker
TECX
According to Tectonic Therapeutic, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -6.70. This represents a change of 38.73% compared to the average of -4.83 of the last 4 quarters.
The mean historical PE Ratio of Tectonic Therapeutic, Inc. over the last ten years is -24.03. The current -6.70 PE Ratio has changed 2.69% with respect to the historical average. Over the past ten years (40 quarters), TECX's PE Ratio was at its highest in in the June 2023 quarter at 0.16. The PE Ratio was at its lowest in in the March 2017 quarter at -88.30.
Average
-24.03
Median
-6.36
Minimum
-160.00
Maximum
-0.29
Discovering the peaks and valleys of Tectonic Therapeutic, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 734.32%
Maximum Annual PE Ratio = -0.29
Minimum Annual Increase = -78.82%
Minimum Annual PE Ratio = -160.00
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -5.15 | -56.16% |
| 2024 | -11.75 | 734.32% |
| 2023 | -1.41 | 380.11% |
| 2022 | -0.29 | -78.82% |
| 2021 | -1.38 | -67.15% |
| 2020 | -4.22 | -44.29% |
| 2019 | -7.57 | -11.33% |
| 2018 | -8.53 | -78.69% |
| 2017 | -40.04 | -74.97% |
The current PE Ratio of Tectonic Therapeutic, Inc. (TECX) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
-6.10
5-year avg
-4.00
10-year avg
-24.03
Tectonic Therapeutic, Inc.’s PE Ratio is greater than Alto Neuroscience, Inc. (-9.17), less than Larimar Therapeutics, Inc. (-1.73), less than Cellectis S.A. (-4.55), less than Lyell Immunopharma, Inc. (-0.75), greater than Amarin Corporation plc (-9.90), less than AC Immune S.A. (-2.93), less than DBV Technologies S.A. (-3.35), greater than Alpha Tau Medical Ltd. (-14.60), less than Silence Therapeutics plc (-1.60), less than Aldeyra Therapeutics, Inc. (-4.29),
| Company | PE Ratio | Market cap |
|---|---|---|
| -9.17 | $798.04M | |
| -1.73 | $311.50M | |
| -4.55 | $299.24M | |
| -0.75 | $297.28M | |
| -9.90 | $331.54M | |
| -2.93 | $244.26M | |
| -3.35 | $371.50M | |
| -14.60 | $883.39M | |
| -1.60 | $327.33M | |
| -4.29 | $118.23M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tectonic Therapeutic, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Tectonic Therapeutic, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Tectonic Therapeutic, Inc.'s PE Ratio?
How is the PE Ratio calculated for Tectonic Therapeutic, Inc. (TECX)?
What is the highest PE Ratio for Tectonic Therapeutic, Inc. (TECX)?
What is the 3-year average PE Ratio for Tectonic Therapeutic, Inc. (TECX)?
What is the 5-year average PE Ratio for Tectonic Therapeutic, Inc. (TECX)?
How does the current PE Ratio for Tectonic Therapeutic, Inc. (TECX) compare to its historical average?